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Abstract
Disruption of the cytoskeleton and axonal transport has been implicated in certain
neurodegenerative diseases such as Alzheimer's disease. It is not clear whether
cytoskeletal and transport abnormalities playa causative role in neurodegeneration or
whether they are simply byproducts of disrupted metabolism and signal transduction
pathways in neurons undergoing apoptosis. Aluminum has been used to induce apoptosis
in both in vivo and in vitro models of apoptosis that share many biochemical and
pathological similarities to Alzheimer's disease. The specific aim of this project was to
examine the effect that aluminum-induced apoptosis has on intracellular distribution of
the endoplasmic reticulum. The results indicate that following aluminum treatment the
endoplasmic reticulum is abnOlmally clustered around the nucleus, consistent with
disruption of kinesin-dependent transport.
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Clustering of the Endoplasmic Reticulum in Aluminum Induced Apoptosis
Intracellular transport is fundamental to cellular activity and functioning.
Virtually all eukaryotic cells organize their cytoplasm by translocating various
membrane-bound vesicles and macromolecular complexes to specific subcellular
locations. The intracellular traffic is not random, but rather is polar transport along a
microtubule network. Microtubules serve as the tracks on which molecular motor
proteins, such as kinesin and dynein, CatTY their cargo. TranspOlt along this cytokeletal
infrastructure is critical, as materials, such as proteins, produced in specific regions must
be transported to maintain other regions of the cell.
Proteins tat'geted for vesicular transpOlt are synthesized by cytosolic ribosomes
and transpOlted into the endoplasmic reticulum (ER). In the ER, proteins are assembled
and folded into polypeptide chains in preparation for their secretion or distribution to
various subcellular compartments. From the ER, proteins are packaged into vesicles and
transpOlted to the Golgi complex. Proteins undergo sorting and processing in the Golgi
before being transported along microtubules to their targeted destinations.
Axonal Transport

Neurons at'e specialized cells for communication by electrical conduction. The
axon, the main cellular process of the neuron, is designed to conduct electrical signals
away from the cell body to adjacent neurons. The axon is suppOlted by cytoskeletal
neurofilaments and a microtubule network that provides the tracks by which proteins and
vesicles are transported along the axon.
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The length of the axon provides the neuron with unique dimensions beyond
comparison to any other cells in the body. Individual axons can reach a length of over
one meter in humans and other large animals and the extreme length-to-diameter ratios
can be as high as

17

in some cases. 57 The volume of cytoplasm in these long axons

accounts for approximately 99% of the cell's volume, while the cell body supplies
virtually all of the cell's proteins, lipids, and other materials. 7 Branching and small
diameters in parts of the axon further add to the challenge of transpOliing the materials
necessary for cellular function and maintenance in axons. Such challenges place
remarkable demands on the neuronal cytoskeleton and associated axonal transport to
develop and maintain the axon. This critical function has led to increasing research
focusing on the role of axonal transport defects in neurodegenerative diseases such as
Alzheimer's disease. 8
With the recognition that the neuronal cell body is

th~

site of synthesis supplying

the necessary materials to the axon, mechanical models for transport of these materials
were proposed. Based on his observation of axoplasm oozing from the proximal ends of
freshly cut giant nerve axons, in 1944 J.Z. Young proposed one of the first models of
mechanical transport. 50 He suggested that a constant production of axoplasm from the
cell bodies creates a pressure forcing the fluid axoplasm down the length of the axon. He
proposed that the axon wall, by exerting an opposite pressure due to surface tension of its
lipid myelin sheath, maintains the cylindrical shape of the axon.
The first major advancement to the modem concept of axonal transport came in
1948, when Paul Weiss and H.B. Hiscoe perfOlmed their "damming" experiment and
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described what would later be termed slow axonal transport. 50 They ligated a nerve trunk
with thread and noticed several days later that the region of the axon before the ligation
was bulging from what they concluded was damming of axoplasm, while the region of
the axon beyond the ligation was narrowing. When the ligature was removed, they noted
that the material proceeded down the axon at the rate of 1-2 mm per day. This
experiment demonstrated the directional flow of axon-maintaining material from the cell
body.
The slow axonal transport observed by Weiss can be subdivided into two
components: slow component A [0.2-1 mm/day] and slow component B [2-8 mrnJday].
Slow transpOlt is well developed in axons and provides the means by which cytoskeletal
materials required for maintaining the axonal cytoskeleton are transpOlted?6 Slow
transport is also responsible for the locomotion of the axon in periods of growth and
regeneration. 34
Whether growing or not, slow axonal transport keeps the axonal polymers in
continuous motion. 36 Slow axonal transport is responsible for moving large amounts of
cytoskeletal matelials; however, it operates on a local level by moving individual
polymers within the axon. 34 The net result of the movement of individual polymers is a
translocation of the entire axonal cytoskeleton towards the telminus of the axon.
Later expeliments with radioactively-tagged amino acids provided evidence for a
second type of axonal transport, one that moves at a much faster rate. 39 Fast axonal
transport, as it was termed, travels at a rate of 200-400 mm per day. Video microscopy
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has allowed researchers to directly view vesicles in giant squid axons undergoing fast
axonal transport. 4 !
Fast axonal transport accounts for vesicular traffic within the axon.! Enzymes,
lipids, and membrane glycoproteins are among the materials canied along the axonal
microtubules via fast axonal transpOlt. Unlike slow axonal transport, fast axonal
transport has been experimentally shown to operate in the anterograde and retrograde
directions. 57
Slow axonal transpOlt has been the subject of some controversy in recent years.
Recent studies have examined neurofilament proteins tagged with green fluorescent
protein (GFP) in cultured rat sympathetic neurons. 6 ! The axons of these neurons contain
relatively few neurofilaments and frequently have gaps lacking neurofilament in their
axonal cytoskeletal network. Time-lapse imaging of these gaps has allowed the
observation of axonal transport without the normal photobleaching or photoactivation
approaches. These studies have produced some surprising results. Contrary to the
standard association of cytoskeletal materials with "slow" transpOlt, neurofilaments have
been observed to move rapidly in the axon, with rates as high as 3 /-lm per second. 62 This
rapid movement is interrupted by long pauses, however. Comparing these rapid bursts to
the net movement of neurofilament proteins at 0.3-3 mm per day, it can be estimated that
neurofilaments spend 83-99% of their axonal transpOlt in these long pauses. 10 The
mechanistic reasons behind these pauses has not been determined.
In 1986, Nixon and Logvinenko used radioisotopic pulse labeling in mouse optic
nerves to propose a model of two kinetically distinct types of neurofilaments. 39 They
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suggested that neurofilament polymers transition between moving and stationary phase as
they travel along the axon. Lasek and his associates, however, challenged this model of
two kinetically different neurofilament populations. 35 Lasek suggested that there is a
single population of neurofilaments in axons and they are all in a continuous state of
movement, albeit at a broad range of rates. Results showing GFP-tagged neurofilaments
moving in altemating fits bursts and pauses do not provide conclusive evidence for either
one of these models. The fits and starts could represent a transition between two distinct
phases or it could represent ilTegular movements of a single population of
neurofilaments.
Another point of controversy in slow axonal transport has been the structural
forms in which the cytoskeletal and cytosolic proteins move. Slow axonal transport
consists not only of cytoskeletal proteins, but a wide range of additional cytosolic
proteins. Lasek proposed a model where these cytosolic proteins are transpolied by
physically associating with moving cytoskeletal polymers.34 The relatively simple
protein composition that makes up slow component A indicates that microtubules and
neurofilaments could act as the only structural carriers for proteins in this component. 10
Proteins in slow component A are either integral paris of the cytoskeletal polymers or
have been shown to associate with these polymers in vivo. Slow component B consists of
a much more diverse and complex protein composition. It is likely that the catTier
structures for slow component B are likewise complex and may consist of several
macromolecular complexes.
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It has been generally held that slow axonal transpOli occurs only in the

anterograde direction. However, observations of GFP-tagged neurofilaments show that
up to 20-30% of the filaments move towards the cell body in a retrograde fashion. 62
Supporting this, in vitro studies have shown neurofilaments moving towards the minus
ends, as well as the plus ends, of microtubules. 48 Retrograde movement of neurofilament
could indicate a distinct population or transient reversals of filaments that have a net
movement in the anterograde direction.
Mitochondlia display unique motility within axons of nerve cells. Unlike many
other types of organelles, mitochondria undergo net movement of both anterograde and
retrograde transport within the axon.27 Mitochondlia serve essential functions of aerobic
ATP production and intracellular calcium regulation to maintain the axon. Movement of
mitochondria is distinguished by three key elements: saltatory movement, with frequent
starts and stops; true bidirectional movement; and prolonged $tationary phases. 27
Rapid-freezing electron microscopy demonstrated cross bridges between
microtubules and mitochondria, indicating that microtubules serve as the tracks for
mitochondrial axonal transport?S Observation of mitochondrial movement in the growth
cone region of growing axons of sympathetic neurons in culture demonstrated that
microfilaments can also serve as mitochondlial tracks. 16 Mitochondria can move
bidirectionally on either set of cytoskeletal tracks, but there are key differences in
motility on the different tracks. Mitochondria are transported at a much higher rate on
microtubules, implying that molecular motors with different characteristics are associated
with mitochondlial transport on the different tracks. 38
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Molecular Motors

To achieve directional transport within the cell, vesicles and organelles must
associate with motor proteins that simultaneously attach to the microtubule network and
provide energy for the movement. These motor proteins move unidirectionally along
microtubules by coupling ATP hydrolysis to force generation. This force allows motor
proteins to cany their cargo to various destinations in the cell.
Evidence for a differential transport of components, and the discovery of a fast
transp0l1 in axons, led to a search for molecular models of transport. In 1964, Lubinska
observed that acetylcholinesterase not only moved anterogradely to accumulate above a
nerve ligation, but also accumulated below a second ligation made more proximal to the
cell body.50 While the total amount of acetylcholinesterase remained the same in a
segment of axon isolated in such a way, it became redistributed as a result of two-way
transport. The presence of both anterograde and retrograde transp0l1 provided evidence
that there is a structure within the neuron's axon that is able to selectively guide axonal
transp0l1. Based on evidence that microtubules are present in the axon and implicated in
the transport process, a basic model was established in which carriers moved along
microtubules using the energy provided by ATP.
The motor proteins associated with the microtubules during intracellular transport
were not discovered until the mid-1980's.58 Evidence that these proteins required
association with both the microtubules and adenosine triphosphate (ATP) pointed to
mechanochemical ATPases as prime candidates. Dynein, like that which operates in the
movement of cilia and flagella, had been discovered in the 1960's and was considered for
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some time. 37 However, advances in technology led to the discovery of the motor protein
kinesin, and two years later, cytoplasmic dynein. 58
Molecular motor proteins function by converting the chemical energy of ATP into
a force that propels molecular motion. Association of the motor proteins with the
microtubules and ATP causes a conformational change in the motor head regions of the
proteins. This conformational change propels the motor proteins and their associated
vesicular cargo along the microtubules.
Kinesin is a 380 kilo Dalton (kD) dimer consisting of two 120-kD heavy chains
and two 64-kD light chains. 26 Kinesin has a rod-like structure with two large globular
heads, made up of the heavy chains, connected by a stalk region to a fan-like tail,
comptised of the light chains. While the head region is directly associated with the
microtubules and ATP, the tail region associates with the membrane vesicles. 19 The head
region of kinesin generates force for movement and is a highly conserved domain. 26 On
the contrary, the tail region has a highly vatiable amino acid sequence. Kinesin is an
anterograde motor protein that moves its cargo towards the plus-end of the microtubule,
or the cell periphery.
Dynein is the second group of motor proteins and transpOlis its cargo along the
microtubules toward the minus-end. Cytoplasmic dynein is a member of the dynein
family that is involved in the movement of vesicles within the cell. It is a huge
multisubunit protein complex (1.2 mega Daltons) and is found in all eukaryotic cells?6 It
consists of two heavy chains (-530 kD), three intermediate chains (74 kD), and four light
intermediate chains (-55 kD). Like kinesin, the two heavy chains comptise two large
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globular heads that associate with the microtubules and ATP. However, dynein cannot
directly associate with its vesicular cargo. Vesicular attachment is thus mediated by
another protein complex known as dynactin. 18
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Figure 1. Structural representation of kinesin and cytoplasmic dynein
motor proteins.
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Transport Betvveen ER and Golgi

A unique fonn of intracellular transport of vesicles occurs between the
endoplasmic reticulum and the Golgi complex. Proteins are assembled and folded in the
ER, packaged into vesicles, and shipped to the Golgi for processing and transpOlt.
Transport between these two structures involves an intelmediate compartment and is
somewhat, though not completely, dependent on microtubules. This specific intracellular
pathway is clitical, as disruption of this transport could result in an accumulation of
proteins that could elicit cellular stress responses.
Proteins that are destined for vesicular traffic in secretory and endocytotic
pathways are synthesized by ribosomes in the cytosol. These proteins are then cotranslationally transported into the lumen or membrane of the ER. After proper folding
and oliogomer assembly, the proteins are incorporated into vesicles for transport to the
Golgi complex. The Golgi complex is responsible for perfonning various tasks such as
glycosylation of many proteins, sorting of proteins into vesicles, and transport of these
vesicles to vatious destinations throughout the cel1. 2
TranspOlt of proteins from the ER to the Golgi complex involves transport
vesicles that bud from the ER membrane and fuse with the membrane of the Goigi
appat·atus. Early studies using pancreatic acinar cells revealed that vesicle budding
occurs in specialized regions of the ER known as transitional elements. 6o This transport
has been demonstrated in vitro using permeabilized cells with added cytosolic fraction,
ATP-regenerating system, and GDP-mannose. 4
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Genetic approaches in Saccharomyces cerevisiae have been important in
identifying many proteins involved in ER to Golgi transpOlt. GO A group of sec genessec12, secl3, sec16, and sec23- seems to be involved in vesicle formation. Another
group of sec genes- sec17, sec18, and sec22- appear to be involved in the fusion of these
vesicles to their targets, such as the Golgi membrane. Another group of proteins, small
GTP binding proteins, play an important role in the ER to Golgi transport. 60 One such
protein is Sarlp, which interacts with sec12 and sec23 proteins and the endoplasmic
reticulum membrane. Sarlp, in conjunction with Sec12p, seems to associate with the
endoplasmic reticulum and promote the formation of transport vesicles by hydrolyzing
GTP. The ARF (ADP-Iibosylating factor) family of proteins also seems to be involved in
ER to Golgi transport and appears to function in the maintenance of the Golgi
apparatus. 12
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Table 1. Protein families involved in transpOli between the endoplasmic reticulum and

the Golgi apparatus.

Table 1
Proteins Involved in ER to Golgi Transport

Family of Proteins

Function

Sec proteins
-sec12, see13, sec16, see23 proteins

Involved in vesicle formation

- see17, sec18, see22 proteins

Involved in fusion of vesicles to targets

Small GTP binding proteins
-Sarlp

In association with ER and Sec12p,
hydrolyzes GTP to promote formation of
transport vesicles

ARF proteins

Involved in maintenance of Golgi structure
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Studies have shown that ER to Golgi transport in mammalian cells involves an
intermediate compartment (IC) between the endoplasmic reticulum and the Golgi. 6o
When cells infected with a temperature-sensitive virus were incubated at 15°C, viral
glycoproteins accumulated in morphologically distinct structures about 300 nm in
diameter. 45 Evidence supports the idea that the IC is a distinct intermediate in ER to
Golgi transport, with no direct continuity with either the ER or the Golgi. The IC appears
to be a dynamic collection of ER transitional elements and vesicular-tubular clusters
(VTC)3. The IC compartment is involved in the anterograde transport of proteins from
the ER to the Golgi and the recycling of proteins retrogradely to the ER.
The retrograde transport of proteins from the Golgi back to the ER has been
another subject of study in ER to Golgi transport. The anterograde transport pathway is
mediated by vesicles covered by a protein coatamer, refened to as COPII. 46 Association
of COPII with vesicles targeted for the ER requires GTP and,may involve the GTPbinding protein ARF. In the retrograde pathway, uncoated, Golgi-derived tubules are
seen and their presence has been demonstrated to be dependent on microtubules. 13
Tubular budding, rather than vesicle mediation, has been implicated in retrograde
transport. 31 This difference in mediation appears evident in experiments that block
anterograde transport using the drug Brefeldin A. Treatment with Brefeldin A results in
the disappearance of the Golgi apparatus and subsequent increase in size of the
endoplasmic reticulum, suggesting that the retrograde pathway dominates. 2
It has recently been clearly demonstrated that transp011 between the intermediate

compartment and the Golgi apparatus occurs along microtubules. 42,46 Evidence came

Transport in Neurodegeneration 18
from cells transfected with VSVG-GFP, a chimaeric protein containing the COOHterminal region of a temperature-sensitive vesicular stomatitis virus glycoprotein fused to
green fluorescent protein. Fluorescence microscopy was used to observe synchronous
transport of the fusion protein through the secretory pathway. IC membranes containing
VSVG-GFP were seen to move along microtubules to the Golgi. 42.46 If the microtubules
are depolymerized, rates of Golgi-dependent protein processing drop dramatically,
indicating that the transport from the IC to the Golgi has been inhibited. If the
microtubules are disrupted by a drug such as nocodazole, the microtubule-dependent
movement from the IC to Golgi is disrupted. However, removal of nocodazole after brief
exposure can lead to the resumption of normal Ie to Golgi transport. 6
Interestingly, disruption of microtubules does not always result in decreased rates
of Golgi-based protein processing or secretion. 32 In these cells that maintain normal
processing or secretion rates there are considerable changes in the distribution of the
Golgi, however. In these cells, the Golgi fragments into ministacks which are distributed
to locations adjacent to endoplasmic reticulum exit sites, at a distance less than 1 !lm. 11
It seems that diffusion-based membrane trafficking is then used and operates at an

efficient level. In contrast, in cells with a functional microtubule network, the Golgi can
be a distance of dozens of micrometers away from the endoplasmic reticulum. 44
Diffusion would not operate at an efficient enough level at such distances.

Effects of Aluminum on Transport
When studying changes in the cytoskeleton and axonal transport in certain
neurodegenerative diseases, it is useful to establish a biochemical and pathological model
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of the disease. If one is able to trigger similar changes in a system, whether it is in vivo
or in vitro, the model may provide clues to the pathological causes of the disease.
Aluminum can be used to induce a model of apoptosis that shares celiain charactelistics
with neuronal death in Alzheimer's disease.
Aluminum is an environmental neurotoxin that has been shown to have an
inhibitory effect on axonal transport. 29 Aluminum has been shown to cause
accumulation of neurofilaments in neuronal pelikarya of certain vertebrate species in vivo
and in vitro. 49 Intrathecal injection of aluminum salts into rabbits induces accumulation
of neurofilaments, associated with dysfunctional metabolic activity and impaired axonal
transport of neurofilaments.

17

Chronic exposure of primary cultured neurons to

aluminum salts also leads to similar neurofilament accumulations in the neuronal
pelikaryon. 49 In addition, pulse exposure of cultured rat cOliical neurons to aluminummaltol causes neurofilaments and fast axonal transpOlied proteins to be abnOlmally
distributed. 29
Neurofilaments are clitical to the integlity of a functional cytoskeleton. Thus,
aluminum-induced abnormalities in neurofilaments would have definite repercussions for
microtubule-dependent axonal transport processes. The impairment of axonal transport
by accumulating neurofilaments is thought to be the mechanistic cause of aluminum
..

tOXICIty.

59

Accumulation of neurofilament proteins and abnormal axonal transport are also
neuronal characteristics of certain neurodegenerative diseases such as Alzheimer's
disease. 8 The neurofibrillary tangles in AD display a similar, though not identical,
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accumulation pattern of phosphorylated neurofilament immunoreactivity.56 Thus, there
may be a similar pathological process causing accumulation of neurofilaments and
disrupted axonal transport in both neurodegeneration and aluminum neurotoxicity.
Inducing such effects using aluminum may then provide a useful model for elucidating
clues about Alzheimer's pathology.
Alzheimer's and Intracellular Transport
Alzheimer's disease is characterized by two chief pathological manifestations.
The first is the presence of extracellular senile plaques composed plimarily of amyloid-~,
a peptide derived from amyloid precursor protein (~PP). 61 The second of the hallmark
characteristics is formation of neurofibrillary tangles. The neurofibrillary tangles consist
of bundles of -10 nanometer paired helical filaments believed to be composed primarily
of hyperphosphorylated tau. 9 It is not clear whether these pathological characteristics are
causes or simply markers of Alzheimer's disease.
The Role of Tau in Neurodegeneration
As researchers try to determine the biochemical and pathological causes of
Alzheimer's disease, they have recognized several proteins as key players in the process.
Tau is a microtubule-associated protein that seems to be critical to the integrity of the
cytoskeletal network. Tau is associated with the neurofibrillary tangles characteristic of
Alzheimer's disease.
Microtubules are stabilized by a group of microtubule-associated proteins (MAPs)
that includes MAP2, MAP4, and tau. 55 These proteins seem to play an important role in
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cytoskeletal organization by binding to the surface of the microtubules and promoting
microtubule assembly.3D Tau is especially prevalent in the axons.
Paired helical filaments in tangles consist of hyperphosphorylated tau. As
discussed, microtubules compose the cytoskeleton of the cell and are involved in various
processes within the cell such as transport of vesicles and organelles. Tau normally
stabilizes microtubules, but when it is abnormally phosphorylated it forms tangles. 23
Accumulation of paired helical filaments is believed to disrupt the cytoskeleton and
axonal transpOlt, affecting cell metabolism and leading to neuronal death. 51
There seems to be a critical regulated balance of tau phosphorylation, distribution,
and concentration within the neuron. Kinases and phosphatases seem to regulate this
balance, which is disturbed in Alzheimer's disease. 8 In AD, tau concentrations are
elevated and tau becomes localized in the somatodendritic pOltion of the neuron 22
Elevation of tau concentrations in AD could be attribllted to overcompensation by
the cell. Upon hyperphosphorylation, tau has reduced affinity for the microtubules 23
The cell may try to compensate by producing more tau. Research shows that
overexpression of tau results in change in cell shape, blocking of kinesin movement, and
altered distribution of organelles and vesicles. 51 Following tau overexpression, there is
perinuclear clustering of the mitochondria at the microtubule-organizing center. Also,
the ER becomes less dense and moves away from the periphery of the cell.
Overexpression of tau and subsequent disruption in axonal transport are similarly
observed in the neurons of Alzheimer's patients. 8
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The role of microtubule transport in abnormal distribution of organelles following
tau expression has been verified by using drugs that affect the microtubule network. Tau
overexpression induces clustering of organelles, however, upon treatment with
nocodazole, a drug that leads to the disassembly of the microtubule network,
mitochondria redistribute themselves throughout the cell, seemingly by diffusion. 14
Removing nocodazole reconstitutes the microtubule network and again leads to
mitochondrial clustering around the microtubule-organizing center. These results
demonstrate that the process of mitochondrial clustering is indeed dependent on
microtubule transpOli.
Distribution of the ER is also dependent on the microtubule network and kinesin
transport. The distribution behavior of the ER, however, seems to involve more than the
mitochondria. Treatment with nocodazole does not cause the ER to expand to its normal
distribution to the cell periphery. The ER is not able to simply diffuse to normal
distribution throughout the cell in the same way that the mitochondria are able to. These
results suggest that distributional transport of the ER is dependent on a functional
microtubule network.
Changes in the distIibution of organelles such as the mitochondria and ER could
have important impacts on the cell. IrTegular distribution of the mitochondlia could lead
to deficient glucose metabolism and ATP synthetase throughout the axon, as
mitochondria may become concentrated in one region and lacking in another. Abnormal
distribution of the ER and disruption of its microtubule-dependent secretory pathways
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could disrupt calcium homeostasis and lipid synthesis. These changes could lead to
neuronal cell death.
The Role of~PP in Neurodegeneration
Another protein that has been the focus of much Alzheimer's research is amyloid
precursor protein

(~PP).

While its function in the cell is still in question, it seems to bind

to kinesin-I and to mediate axonal transport.
characteIistic of Alzheimer's disease,

A~

~PP

is associated with the other hallmark

senile plaques.

Kinesin-I is suggested to be the motor protein responsible for fast anterograde
axonal transport. 58 This motor protein has not been clearly linked to a patiicular type of
vesicular cargo, nor has a protein receptor assisting in kinesin-I' s binding to its vesicular
cargo been definitely identified. One of the pIime candidates, however, is

~PP. ~PP

has

been found to mediate the axonal transpOli of presenilin-l and ~-secretase.53 ~PP has
been linked to the initiation and/or progression of Alzheimer',s disease and has been a
target of much neurodegenerati ve research.
~PP

is an integral transmembrane protein whose normal role in cellular function

has not been firmly established.

~PP

proteins mature in the ER and Golgi apparatus and

undergo post-translational modification such as glycosylation and phosphorylation.

U-, ~

, and y-secretases are the three putative proteases that have been implicated in the
cleavage of mutant ~pp.15 Proteolytic cleavage of ~PP results in the fOlmation of A~
peptides of vaIious lengths, though typically consisting of 40 or 42 residues.

A~

peptides

normally exist as soluble monomers, but aggregate into insoluble, fiblillar plaques in the
brains of AD patients. G3
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Fragments of ~PP are abundant in the senile plaques characteristic of AD. 53
Some forms of familial Alzheimer's disease are caused by mutants of the

~PP

gene.

Research shows that theses mutants lead to an increase in the number of senile plaques
and an increase in the proteolytic ~PP fragments in these plaques. 47 Abnormal trafficking
of ~PP has also been suggested as an initiation factor of AD. Evidence of ~PP's direct
binding to kinesin-I further links it to the disruption of axonal transport characteristic of
AD.
While there is controversy over the role of axonal transport defects in the
initiation of AD, evidence suggests that
initiation of AD.

~PP

~PP's

role in transpOlt could be related to

appears to bind directly to kinesin-I and thus is in intimate contact

with the axonal transport network. Organelle and vesicle accumulations are eady
changes in morphology in mouse, and perhaps human, models of Alzheimer's disease. 2o
Overexpression of a ~PP homolog, APPL, in Drosophila reslllts in similar axonal clogs
and disrupts axonal transport. 54 Also, while ~PP is widely expressed in the body, cellular
characteristics of Alzheimer's disease are primarily limited to the neurons. Long axonal
processes are a distinguishing characteristic of neurons and the critical function of
transport along these long axons may be important to the development of AD.
The idea that altered neuronal transpOlt is critical in inducing neuronal death is
further supported by experiments with axonal blockages. It has been found that reducing
the amount of kinesin in the axons made blockages worse. On the other hand, reducing
the amount of dynein or presenilin, a protein responsible for cleavage of ~PP, somewhat
relieved the axonal blockages.
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Improperly processed

~pp

may accumulate and lead to axonal clogging.

Increased A~ secretion as a function of stressed neurons may lead to the aggregation of
amyloid-~ (A~)

in senile plaques. This may further disrupt axonal transport and act a

causative role in neurodegeneration.
Research shows that
amyloid-~

~pp

causing neuronal death contains two key regions: the

region and the C-terminus. Enzymatic cleavage of the C-telminus liberates

kinesin because the C-terminus includes the kinesin-binding site. The C-terminus may
carry a cell-death signal that is released when axonal transport is disrupted.
Evidence from other models has indicated that defects in transport playa critical
role in neurodegeneration. Apolipoprotein E (ApoE) is a protein that plays an impOliant
role in lipid transpOli and is produced in a variety of cells, such as kidney, liver, and fat
cells. In the brain, ApoE is mainly produced by astrocytes and is important in lipid
transport within the nervous system. ApoE gene has been lin,ked to increased plaque
formation in Alzheimer's disease and the early stages of neurofibrillar·y tangles. 52
Neurons undergo uptake and synthesis of ApoE and the regions of the brain where ApoE
is present are shown to be more susceptible to neurofibrillary tangles.
Expression of human ApoE4 in the neurons of mice produced axonal transport
abnormalities, such as accumulation of organelles, and resulted in decreased sensorimotor
abilities. 52 Expression of ApoE4 also results in the hyperphosphorylation of the protein
tau in the brain and spinal cord, though the mechanism tying these two together is not
known. This hyperphosphorylation affects the stability of the microtubules and disrupts
axonal transport.
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The cytoskeleton and its associated network of intracellular transportation are a
clitical area of study and research, particularly for their role in neurodegenerative
diseases such as Alzheimer's disease. It is clear that the integrity of the cytoskeleton and
transport mechanisms is required for function and survival of neurons. Not surprisingly,
many neurodegenerative diseases are characterized by abnOlmalities in the cytoskeleton
and accompanying intracellular transport malfunction. In Alzheimer's disease,
cytoskeletal abnormalities are so integral that they serve as the basis for the classification
of the progressive stages of the disease. 8
Although cytoskeletal and transport abnormalities provide the hallmarks of many
neurodegenerative diseases, the role they play in the development of the disease is not
clear. Specifically, it is not clear whether these abnOlmalities playa causative role in
neurodegeneration or whether they are simply byproducts of disrupted metabolism and
signal transduction pathways in degenerating neurons. Thus"continued research in the
role of changes in the cytoskeleton and transport is critical, as they may actively
contribute to neuronal death and may serve as potential therapeutic targets.
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Introduction
Changes in the cytoskeleton and intracellular transpOli were observed in an in

vitro model of apoptosis. Al-maltolate was used to induce apoptosis in cultured human
neuroblastoma cells. Specifically, staining techniques were used to observe the effect
that Al-maltolate treatment has on the intracellular distribution of the endoplasmic
reticulum. If Al-maltolate affects the intracellular transpOli of the ER, observed changes
in the density, brightness, and branching of the ER would be expected. The ER is
normally highly branched and distributed throughout the cell. If the ER is retracted
toward the nucleus following treatment, however, this would provide evidence that Almaltolate affects kinesin dependent transport
Cell counts were used to establish aluminum's toxicity in the in vitro model. To
verify that transport effects are specific to Al-maltolate, hydrogen peroxide was also used
tligger oxidative stress and apoptosis. Examining changes in,such representative models
may provide clues to the underlying pathological causes of certain types of
neurodegenerati ve diseases.
Methods
Cell Culture

Human neuroblastoma (NT2) cells (Stratagene) were grown on glass covers lips in
D-MEMIF-12 (Gibco) growth medium with 10% (v/v) PBS, 2mM L-glutamine and 1%
(v/v) penicillin-streptomycin and kept in 5% CO 2 at 37°C and 95% humidity. Cells were
grown at a density of 1 x 105 / mL on the glass coverslips and kept in 6-well plates.
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Alum.inum Treatment

Fresh aluminum maltolate was prepared as a stock solution of 25 mM in sterile
water and filtered through a 0.2 mm filter. Cells were allowed to adhere for 24 hours in
media containing 0 to 500

~lM

Al-maltolate before the media was replaced.

Hydrogen Peroxide Treatment

A solution of 0.03% hydrogen peroxide was prepared in stelile water. Cells were
incubated in the hydrogen peroxide solution for 30 minutes before the solution was
replaced with fresh media.
Visualization of the Endoplasmic Reticulum

For each six-well plate, three wells containing NT2 cells were incubated in 500
~M

Al-maltolate solution and three wells were incubated in fresh media as controls. To

visualize the effects on the endoplasmic reticulum, ER-Tracker ™ Blue-White DPX
(Molecular Probes) was added. This is a fluorescent dye that.specifically detects ER.
CMXRos Mitotracker Red was added 2~LllOmL for 20 minutes, in order to visualize the
mitochondria. Following the appropriate incubation, cells were fixed in 4%
formaldehyde for 15 minutes and then washed with PBS three times. This solution was
removed with three Ix PBS washes. Coverslips were mounted onto glass slides using
VectaShield (Vecta Laboratories) and cells were viewed with an Olympus microscope
and pictures were taken with a digital camera.
Cell Counts

Using the Olympus microscope and a digital camera, pictures of ten random, but
representative, fields were taken for each coverslip. Using Image Pro Plus software, the
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number of cells per viewing field was calculated by counting the number of nuclei
stained with Hoechst 33258. Apoptotic cells were identified by strongly condensed or
fragmented nuclei. Using the total number of cells per coverslip and the conesponding
number of apoptotic cells, a percentage of apoptotic cells were calculated for each
coverslip.
Results
Cell Count- % Apoptotic Cells

Hoescht-stained cells were identified as apoptotic based on several criteria,
including: cell shrinkage, strongly condensed nuclei, and fragmentediilTegular nuclei.
Percentage of apoptotic cells were calculated for Al-maltolate treated and control cells at
6- and 24-hour incubation periods. Percentages of apoptotic cells in the AI-treated cells
for 6- and 24-hour incubation periods were 10.16% and 30.82%, respectively, in the first
trial. The second trial yielded percentages of apoptotic cells for 6- and 24- hour
incubations of 33.4% and 45.4%, respectively. Results for the control and AI-treated
cells in both experimental trials are summarized in Figure 2.
AI-induced Changes in the Endoplasmic Reticulum

To visualize the effects of aluminum treatment on the cells, an ER-Tracker ™
Blue-White DPX (Molecular Probes) was used. The ER appeared dense and branched in
control cultures, and was extended throughout the cell to the cell's periphery (Figure 3).

In AI-treated cells, however, the ER appeared less dense and clustered around the nuclei
of the cells (Figure 3).
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Figure 2, Cell number decreased significantly over 24 hours with Al-maltolate treatment

(top), In addition, a significant increase in the percentage of strongly condensed,
fragmented, and/or irregular nuclei was observed following incubation with 500
maltolate (bottom),
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Figure 3. ER-Tracker ™ Blue-White DPX reveals clustering of the endoplasmic

reticulum around the nucleus in NT2 cells incubated in Al-maltolate for 6 hours (left).
The endoplasmic reticulum ofNT2 cells in control media is highly branched and
extended to the cell periphery (right).
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Hydrogen Peroxide-induced Changes in the Endoplasmic Reticulum

The effects of hydrogen peroxide were also visualized using ER-Tracker ™ BlueWhite DPX. The ER appeared dense and branched in control cultures, and was extended
throughout the cell to the cell's peliphery (Figure 3). In cells treated with hydrogen
peroxide, however, the ER appeared decreased and clustered around the nucleus (Figure
4). Additionally, the cell itself was greatly reduced in size after hydrogen peroxide
treatment.
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Figure 4. NT2 cells incubated in hydrogen peroxide have endoplasmic reticulum
clustered arolmd the nucleus, as revealed by ER-Tracker ™ Blue-White DPX. In
addition, the cell itself was greatly reduced in size following hydrogen peroxide
treatment.
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Discussion
For this study, an effective model of apoptosis was produced using Al-maltolate.
The results indicate that a significant percent of cells were apoptotic following aluminum
treatment based on certain apoptotic clitelia: cell shrinkage, strongly condensed nuclei,
and fragmentedlinegular nuclei. Apoptosis has been implicated Alzheimer's disease and
our model shares many biochemical and pathological characteristics with this
neurodegenerative disease.
This study specifically examined the effect of aluminum treatment on intracellular
distribution of the endoplasmic reticulum. The ER is the primary site of protein synthesis
and assembly in the cel1. 2 However, the ER is also involved in controlling intracellular
Ca2+ levels and regulating cellular responses to stress. Disruption of Ca2+ homeostasis,
inhibition of protein glycosylation, and accumulation of misfolded proteins in the ER can
all result in ER stress that ultimately leads to apoptosis.

43

While mitochondria has received much attention for its role in apoptosis and
neurodegeneration, studies of the involvement of the ER in the pathogenesis of
neurodegenerative diseases have been relatively few. Research has suggested that ER
may also play an important role in stress-mediated cell death induced by a wide vatiety of
insults. Prolonged ER stress and associated misfolded proteins are linked to the
pathogenesis of certain neurodegenerative diseases such as Alzheimer's.43 However, the
role of the ER in initiating cell death after prolonged stress is poorly understood.
The Golgi apparatus is involved with the ER in the vesicular traffic of proteins.
Transport between these two structures is at least partially dependent on microtubules. 46
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Disruption of this microtubule-mediated transport may lead to the fragmentation of the
Golgi apparatus. Treatment with the microtubule-disrupting agent, nocodazole, causes
Golgi proteins to be redistributed to the exit sites of the ER.21 Disruption of ER to Golgi
transport could cause an accumulation of proteins and lead to stress-mediated cell
death. 43
The results of this study show that treatment with Al-maltolate has significant
effects on intracellular transport of the ER. In treated cells, the ER appeared to be less
dense and retracted around the nucleus. These results are consistent with the idea that
transport along the microtubules in the kinesin-dependent, plus-end direction is disrupted.
The inhibition of kinesin-dependent transport of the endoplasmic reticulum indicated by
our results is reminiscent of the morphological effects of tau and A~ overexpression. 14
One of the hallmarks of Alzheimer's disease is the presence of cytoskelatal
abnormalities such as neurofibrillary tangles. 9 This study ind,icates that an AI-induced
model of apoptosis produces pathological changes in the cytoskeletal transport system
similar to those found in such neurodegenerative diseases. Understanding the underlying
pathological processes may help us to develop treatments that target the cause of the
disease, rather than the effects.
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